InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+295.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sheikh Michael, Chairman & CEO. Officer active across 1 company, notably Bioxytran, INC. Aggregated, 8 disclosures have been logged. Activity tracked since 4 June 2021. The latest transaction was filed on 24 October 2024 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
6,473,921 shares@ US$0.54579.0% of flowPreferredSEC:0001754429-24-000011:0
8,000,000 shares@ US$0.0030.5% of flowcommonSEC:0001754429-24-000006:0
1,600,000 shares@ US$0.0150.5% of flowpreferredSEC:0001754429-24-000006:1
800,000 shares@ US$0.0030.1% of flowcommonSEC:0001445815-23-000011:0
1,871,085 shares@ US$0.1436.29% mcap28.6% of flowCommonSEC:0001539497-22-000083:0
1,871,085 shares@ US$0.1436.29% mcap57.2% of flowCommonSEC:0001539497-22-000083
1,643,285 shares@ US$0.134.71% mcap21.4% of flowCommonSEC:0001539497-21-000794:0
1,643,285 shares@ US$0.134.3% of flowCommonSEC:0001539497-21-000794
8 of 8 declarations
About Sheikh Michael
Michael K. Hargrave serves as Chief Executive Officer and Executive Vice President at BIOXYTRAN, INC. He leads the company with a strategic vision, focusing on growth and innovation. His role involves overseeing daily operations and formulating strategies to maximize shareholder value.
